000 01127 a2200325 4500
005 20250514235200.0
264 0 _c20050901
008 200509s 0 0 eng d
022 _a0009-9236
024 7 _a10.1016/j.clpt.2005.04.001
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aUyama, Yoshiaki
245 0 0 _aSuccessful bridging strategy based on ICH E5 guideline for drugs approved in Japan.
_h[electronic resource]
260 _bClinical pharmacology and therapeutics
_cAug 2005
300 _a102-13 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aClinical Trials as Topic
_xstandards
650 0 4 _aDrug Approval
650 0 4 _aGuidelines as Topic
650 0 4 _aHumans
650 0 4 _aInvestigational New Drug Application
650 0 4 _aJapan
700 1 _aShibata, Taro
700 1 _aNagai, Naomi
700 1 _aHanaoka, Hideki
700 1 _aToyoshima, Satoshi
700 1 _aMori, Kazuhiko
773 0 _tClinical pharmacology and therapeutics
_gvol. 78
_gno. 2
_gp. 102-13
856 4 0 _uhttps://doi.org/10.1016/j.clpt.2005.04.001
_zAvailable from publisher's website
999 _c15723317
_d15723317